Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists.

Meynaar, Iwan A; van Rijn, Simone; Ottens, Thomas H; van Burgel, Nathalie D; van Nieuwkoop, Cees

Meynaar, Iwan A; van Rijn, Simone; Ottens, Thomas H; van Burgel, Nathalie D; van Nieuwkoop, Cees.

Meynaar IA; Department of Intensive Care, Haga Teaching Hospital, The Hague, Netherlands. iwanmeynaar@gmail.com.
van Rijn S; Department of Infection Prevention and Control, Haga Teaching Hospital, The Hague, Netherlands.
Ottens TH; Department of Intensive Care, Haga Teaching Hospital, The Hague, Netherlands.
van Burgel ND; Department of Microbiology, Haga Teaching Hospital, The Hague, Netherlands.
van Nieuwkoop C; Department of Internal Medicine, Haga Teaching Hospital, The Hague, Netherlands.

Intensive Care Med ; 48(7): 954-957, 2022 07.

Article in English | MEDLINE | ID: covidwho-1877810

Subject(s)

COVID-19 Drug Treatment; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Cross Infection; Sepsis; Catheter-Related Infections/complications; Catheterization, Central Venous/adverse effects; Central Venous Catheters/adverse effects; Cross Infection/etiology; Dexamethasone/adverse effects; Humans; Interleukins; Sepsis/complications

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Catheterization, Central Venous / Cross Infection / Sepsis / Catheter-Related Infections / Central Venous Catheters / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Intensive Care Med Year: 2022 Document Type: Article Affiliation country: S00134-022-06750-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google